Comparison of counter immunoelectrophoresis with immunoblotting for detection of anti-extractable nuclear antigen antibodies in systemic lupus erythematosus

Asian Pacific Journal of Allergy and Immunology

Volumn 17, Issue 4, 1999, Pages 275-279

  Chan, Eric Y T ^a   Mok, Temy M Y ^a   Lawton, John W M ^a   Ko, Otis K H ^a   Ho, Lily ^a   Lau, C S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLINE;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; COUNTER IMMUNOELECTROPHORESIS; DISEASE ACTIVITY; DISEASE MARKER; HEMOLYTIC ANEMIA; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANEMIA, HEMOLYTIC; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; AUTOANTIGENS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; IMMUNOBLOTTING; IMMUNOELECTROPHORESIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RIBONUCLEOPROTEINS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RNA, SMALL CYTOPLASMIC; SENSITIVITY AND SPECIFICITY;

EID: 0032718433     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-145.
2. Lee SS, Li CS, Li PCK. Clinical profile of Chinese patients with systemic lupus erythematosus. Lupus 1993; 2: 105-9.
3. Wong KL. Pattern of SLE in Hong Kong Chinese: A cohort study. Scand J Rheumatol 1992; 21: 289-296.
4. Clotet B, Guardia J, Pigrau C, Lience E, Murcia C, Pujol R, Bacardi R. Incidence and clinial significance of anti-ENA antibodies in systemic lupus erythematosus. Estimation by counterimmunoelectrophoresis. Scand J Rheumatol 1984; 13: 15-20.
5. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
6. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992; 35:630-640.
7. Wallington T, Gooi H. In Clinical immunology-A practical approach. Gooi H, ed. Chapel H. IRL Press 1990.
8. Van Venrooij WJ, Charles P, Maini RN. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Methods 1991; 140: 181-9.
9. Hiepe F, Kiesdig ST, Yamamoto K, Prokop G, Mielke F, Lukowsky A, Schlaak B, Miyamoto T, Apostoloff E. Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting-comparing with counter electrophoresis. Z Rheumatol 1990; 49: 304-309.
10. Hauke G, Luhrmann R, Metz B, Peter HH. Detection of antibodies to extractable nuclear antigens with counter immunoelectrophoresis and the Western blot technic. Z Rheumatol 1988; 47: 26-9.
11. Yamanaka K, Takasaki Y. Anti-PCNA antibody. Rinsho-Byori 1993; 41: 888-96.
12. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994: 152: 3685-92.
13. Chan EYT, Ko SCW, Lau CS. Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus. Asian Pac J Allergy Immunol 1997; 15:3-7.
14. Wigfall DR, Sakai RS, Wallace DJ, Jordan SC: Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: relationship to clinical activity. Clin Immunol Immunopathol 1982; 47: 354-62.
15. Alcocer-Varela J, Alarcon-Riqualme M, Laffon A, Sachez-Madrid F, Alarcon-Segovia AD. Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL-2. J Autoimmun 1991; 4: 935-45.
16. Silverman ED, Buyon J, Laxer RM, Hamilton R, Bini P, Chu JL, Elkon KB. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus. Clin Exp Immunol 1995; 100: 499-505.
17. Buyon JP. Neonatal lupus syndromes. Curr Opin Rheumatol 1994; 6: 523-529.
18. Buyon JP. Neonatal lupus syndrome. Curr Opin Rheumatol 1996; 8: 485-90.
19. Buyon JP, Winchester RJ, Slade SG, Amett F, Copel J1 Friedman D, Lockshin MD. Identification of mothers at risk for congenital heart block and other neonatal syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993; 36: 1263-73.
20. Lee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M. The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol 1994; 130: 1262-8.
21. Chretien P, Soulie E, Johanet C, Abuaf N. Comparisons of double immunodiffusion, ELISA, Western blot and cape blot for the detection of anti-SSA antibody: study of anti-SSA prevalence in systemic lupus erythematosus. J Autoimm 1994; 7: 379-88.
22. Ben-Chetrit E, Chan EKL, Sullivan KF, Tan EM. A 52 kD protein is a novel component of the SSA/Ro antigenic particle. J Exp Med 1988; 167: 1560-71.
23. Boire G, Gendron M, Monast N, Bastin B, Menard HA. Purification of antigenically intact To ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol 1995; 100: 489-98.
24. Itoh Y, Reichlin M. Autoantibodies to the Ro/SSA antigen are conformation dependent I: anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein. Autoimmunity 1992; 14: 57-65.
25. Itoh Y, Itoh K, Frank MB, Reichlin M. Autoantibodies to the Ro/SSA antigen are conformation dependent II: antibody to the denatured form of 52 kD Ro/SSA are a cross reacting subset of antibodies to the native 60 kD Ro/SSA molecule. Autoimmunity 1992; 14: 89-95.
26. Slobbe RL, Pruijn, GJ, Damen WG, van der Kemp JW, van Venrooij WJ. Detection and occurrence of the 60-and 52-kD Ro (SS-A) antigens and of autoantibodies against these proteins. Clin Exp Immunol 1991; 86: 99-105.
27. Gordon T, Mavrangelos C, McCluskey J. Restricted epitope recognition by precipitin anti-La/SS-B-positive sera. Arthritis Rheum 1992; 35: 663-6.
28. Beer R, Rischmueller M, Coates T, Purcell A, Keech C, McCluskey J, Gordon T. Nonprecipitating anti-La (SS-B) autoantibodies in primary Sjögren's syndrome. Clin Immunol Immunopathol 1996; 79: 314-8.